Gestational Diabetes News and Research

RSS

Gestational diabetes is diabetes that is found for the first time when a woman is pregnant. Out of every 100 pregnant women in the United States, three to eight get gestational diabetes. Diabetes means that your blood glucose (also called blood sugar) is too high. Your body uses glucose for energy. But too much glucose in your blood can be harmful. When you are pregnant, too much glucose is not good for your baby.

Scientists uncover cellular cause of heart defects in babies born to women with diabetes

When women with diabetes become pregnant, they face not only the typical challenges of pregnancy and impending parenthood, but also a scary statistic: they're five times more likely to have a baby with a congenital heart defect.

30 Nov 2023

Maternal exercise shapes early yolk sac growth, varies with baby's sex

This study in Scientific Reports reveals that maternal physical activity impacts yolk sac development in early pregnancy, with effects varying based on gestational age and the sex of the embryo, underscoring the nuanced relationship between maternal behavior and embryonic growth.

23 Nov 2023

Beyond insulin: Medi-Cal expands patient access to diabetes supplies

June Voros sprang from her couch as a high-pitched beep warned her that she needed a quick dose of sugar.

17 Nov 2023

Ketogenic diets and diabetes: A promising match or a questionable pair?

A recent research article in "Diabetes Therapy" examines the effectiveness of ketogenic diets in managing Type 1, Type 2, and gestational diabetes. Despite potential benefits like weight loss and improved glycemic control, the study highlights unresolved issues and the need for more extensive research before incorporating ketogenic diets into clinical guidelines for diabetes management.

16 Nov 2023

Maternal metabolic conditions linked to children's neurodevelopmental risks, study shows

Study investigates how maternal metabolic conditions like pregestational diabetes, gestational diabetes, and obesity mediate the risk of neurodevelopmental conditions in children. It highlights the significant role of obstetric and neonatal complications in this relationship, emphasizing the need for managing these complications to mitigate children's risk of developing conditions like ADHD and autism.

12 Nov 2023

Using TNF inhibitors during pregnancy not associated with worse fetal or obstetric outcomes

According to new research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, continuing tumor necrosis factor inhibitors during pregnancy is not associated with worse fetal or obstetric outcomes and may reduce the risk of severe maternal infections during pregnancy (Abstract #0477).

7 Nov 2023

Cutting-edge 'precision medicine' shows great potential to improve diabetes care

Cutting-edge “precision medicine” has great potential to advance the diagnosis, treatment and ultimate prevention of different forms of diabetes, an international coalition of scientists reports in a sweeping assessment of the state of the field around the world.

6 Nov 2023

Pregnant women in blighted neighborhoods have higher testosterone levels, study finds

Pregnant women living in blighted neighborhoods with high levels of known stressors have higher levels of testosterone – the primary sex hormone in males -- which disrupt hormone regulation and may lead to life-threatening complications during and after childbirth, according to Rutgers research.

3 Nov 2023

Citrus compounds show zesty promise in type 2 diabetes management

Citrus compounds show promise in type 2 diabetes management, reducing blood glucose and mitigating metabolic complications without a clear threshold in humans for bioflavonoid efficacy.

2 Nov 2023

AI shows promise in predicting type 2 diabetes but faces hurdles for clinical use

Researchers have conducted a comprehensive review of AI-based models for predicting type 2 diabetes, revealing their potential for individualized risk assessment and preventative care. Despite promising results, the study calls for more extensive validation and collaboration between AI and medical experts for effective clinical application.

26 Oct 2023

Study challenges link between low birth weight and childhood neurodevelopmental issues

A recent study in JAMA Psychiatry used Mendelian Randomization to examine the link between low birth weight and neurodevelopmental issues in children. The research found no causal relationship between maternal genetic factors affecting birth weight and offspring neurodevelopment, although some evidence suggested that fetal genetic variants may play a limited role.

25 Oct 2023

Linking perinatal events to juvenile idiopathic arthritis-uveitis

Researchers investigate perinatal events associated with the manifestation of juvenile idiopathic arthritis and the development of JIA-uveitis.

20 Oct 2023

$12.5 million grant awarded to NYU Langone Health for developing digital tool to reduce maternal mortality

The maternal mortality rate in the United States, which has doubled in the past 20 years, is higher than in any other industrialized nation.

16 Oct 2023

Early pregnancy obesity linked to heart risks and complicated births

Study reveals a significant link between obesity in early pregnancy and adverse pregnancy outcomes, which in turn are associated with elevated cardiovascular disease risk later in life. The findings suggest the importance of early interventions to mitigate long-term health risks.

12 Oct 2023

Obesity before or during pregnancy can be the root cause of future cardiovascular disease

Pregnancy complications such as preeclampsia and gestational diabetes have recently been associated with a higher risk of developing heart disease later in life.

10 Oct 2023

Obesity in early pregnancy linked to increased cardiovascular disease risk later in life

Having obesity before and during early pregnancy appears to be a strong indicator of risk for developing future cardiovascular disease and was significantly linked with adverse outcomes during pregnancy such as high blood pressure, preeclampsia, and gestational diabetes, according to a study published in Circulation Research that was funded by the National Institutes of Health.

10 Oct 2023

Precision medicine for gestational diabetes management

Precision markers to predict effective lifestyle and pharmacological interventions to manage Gestational Diabetes Mellitus.

9 Oct 2023

Early metformin therapy falls short in curbing gestational diabetes woes

In a significant randomized clinical trial, early metformin therapy was tested for its potential to lessen insulin dependence and enhance glycemic control in gestational diabetes-afflicted pregnant women; however, it yielded no improvements in diabetes symptoms. While metformin reduced maternal weight gain, its effects on primary diabetes symptoms and other secondary outcomes like infant weight gain were mixed, indicating a need for further focused research to unravel these associations.

4 Oct 2023

Tirzepatide outshines other treatments in lowering blood sugar and weight for type 2 diabetes patients

Meta-analysis finds tirzepatide to be the most effective GLP-1 receptor agonist for glucose and weight control in type 2 diabetes patients. The study suggests tirzepatide could be preferable in initial stages of the disease, while other GLP-1 receptor agonists combined with insulin are equally effective for long-term diabetics.

25 Sep 2023

Placental disease: A key contributor to unexplained pregnancy loss

New study in Reproductive Sciences identifies placental diseases as the likely cause for 99% of unexplained pregnancy losses, shedding light on miscarriages and stillbirths. The research suggests that identifying specific placental pathologies could lead to more preventative measures.

21 Sep 2023